Back to top

vaccines: Archive

Mark Vickery

Huge Jobs Number: 531K, 4.6% Unemployment; Did Pfizer Cure Covid?

The private sector alone brought 604K jobs, more than a third of which came from the Leisure & Hospitality and Professional & Business Services sectors.

PFENegative Net Change QQQPositive Net Change SPYPositive Net Change DIAPositive Net Change

Mark Vickery

Jobless Claims at New Post-Covid Lows, MRNA Misses by a Mile

Initial Jobless Claims have now hit a new post-Covid low 269K -- down for the fifth straight week and closer to the 225K per week levels we'd seen prior to the pandemic.

ADPPositive Net Change MRNANegative Net Change

Mark Vickery

ADP: 571K New Private-Sector Jobs, Better than Expected

571K new private-sector jobs in October surpassed the analyst estimate of 398K by a ton.

ADPPositive Net Change PFENegative Net Change BNTXNegative Net Change

Zacks Equity Research

Pfizer (PFE) Q3 Earnings Top, COVID Vaccine Drives 2021 View Up

Pfizer (PFE) beats third-quarter estimates for earnings and sales, and lifts guidance for 2021.

BMYNegative Net Change PFENegative Net Change AMGNNegative Net Change BNTXNegative Net Change

Mark Vickery

Fed Meets, Tapering in Our Midst; Pfizer Beats in Q3

The question now is: when will the Fed start tapering, and by how much?

ADPPositive Net Change PFENegative Net Change

Zacks Equity Research

Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?

On Novavax's (NVAX) upcoming third-quarter earnings call, investor focus is likely to be on the company's progress with its COVID-19 vaccine candidate NVX-CoV2373.

REGNNegative Net Change EXELNegative Net Change NVAXNo Net Change GRTXPositive Net Change

Zacks Equity Research

Biotech Stock Roundup: BMY's Q3 Earnings Beat, MRNA's Vaccine Updates & More

Earnings and other updates from bigwigs like Bristol Myers (BMY) and Moderna (MRNA) have been the biotech sector's few key highlights during the past week.

REGNNegative Net Change SNYNegative Net Change BMYNegative Net Change MRKNegative Net Change GILDNegative Net Change VRTXPositive Net Change MRNANegative Net Change

Sweta Jaiswal, FRM

Will Pfizer ETFs Gain on Positive COVID-19 Booster Dose Data?

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging update in the coronavirus vaccine.

PFENegative Net Change PJPNegative Net Change IHENegative Net Change FDLNegative Net Change IEIHPositive Net Change BNTXNegative Net Change

Mark Vickery

Reasons for Optimism: Q3 Earnings, Infrastructure

Not only good Q3 numbers, but Covid vaccine news and hope for an infrastructure passage are keeping bullish sentiment in the market.

PFENegative Net Change AXPPositive Net Change VFCNegative Net Change SNAPPositive Net Change BNTXNegative Net Change

Kinjel Shah

Pharma Stock Roundup: JNJ Mixed Q3 Results, FDA Nod to Mix & Match COVID Boosters

J&J (JNJ) beats estimates for earnings but misses the same for sales. FDA authorizes mix and match of COVID vaccine boosters.

SNYNegative Net Change GSKNegative Net Change RHHBYNegative Net Change JNJNegative Net Change PFENegative Net Change MRKNegative Net Change ABBVNegative Net Change

Sweta Jaiswal, FRM

Can Biotech ETFs Gain From Positive Booster Update?

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

JNJNegative Net Change MRNANegative Net Change IBBNegative Net Change XBINegative Net Change BBHNegative Net Change FBTNegative Net Change BTECPositive Net Change